1 |
Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884.
DOI
|
2 |
Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2000;54:615-620.
DOI
|
3 |
Dimachkie MM, Barohn RJ, Katz J. Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin 2013;31:533-555.
DOI
|
4 |
O’Leary CP, Willison HJ. The role of antiglycolipid antibodies in peripheral neuropathies. Curr Opin Neurol 2000;13:583-588.
DOI
|
5 |
Larue S, Bombelli F, Viala K, Neil J, Maisonobe T, Bouche P, et al. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Eur J Neurol 2011;18:899-905.
DOI
|
6 |
Remiche G, Kentos A, Mavroudakis N. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant? Acta Neurol Belg 2010;110:103-106.
|
7 |
Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-324.
DOI
|
8 |
Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, et al. Frequency and clinical correlates of anti-neuronal IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994;36:416-424.
DOI
|
9 |
Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 1999;22:800-822.
DOI
|
10 |
Rinaldi S, Willison HJ. Ganglioside antibodies and neuropathies. Curr Opin Neurol 2008;21:540-546.
DOI
|